eyewash station additive concentrate

Generic: chlorhexidine gluconate and propylene glycol

Labeler: niagara pharmaceuticals inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name eyewash station additive concentrate
Generic Name chlorhexidine gluconate and propylene glycol
Labeler niagara pharmaceuticals inc.
Dosage Form LIQUID
Routes
OPHTHALMIC
Active Ingredients

chlorhexidine gluconate 145.6 kg/2800L, propylene glycol 280 kg/2800L

Manufacturer
Niagara Pharmaceuticals Inc.

Identifiers & Regulatory

Product NDC 65785-034
Product ID 65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M018
Listing Expiration 2026-12-31
Marketing Start 2011-11-15

Pharmacologic Class

Classes
decreased cell wall integrity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 65785034
Hyphenated Format 65785-034

Supplemental Identifiers

UNII
MOR84MUD8E 6DC9Q167V3

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name eyewash station additive concentrate (source: ndc)
Generic Name chlorhexidine gluconate and propylene glycol (source: ndc)
Application Number M018 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 145.6 kg/2800L
  • 280 kg/2800L
source: ndc
Packaging
  • .236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01)
source: ndc

Packages (1)

65785-034-01 .236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01)

Ingredients (2)

chlorhexidine gluconate (145.6 kg/2800L) propylene glycol (280 kg/2800L)

Linked Drug Pages (1)

Eyewash Station Additive Concentrate ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "445cd72e-831c-98c4-e063-6294a90a7bdc", "openfda": {"unii": ["MOR84MUD8E", "6DC9Q167V3"], "spl_set_id": ["362a6b6d-862d-4322-87a8-5b3a07fbe174"], "manufacturer_name": ["Niagara Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": ".236 L in 1 BOTTLE, UNIT-DOSE (65785-034-01)", "package_ndc": "65785-034-01", "marketing_start_date": "20111115"}], "brand_name": "Eyewash Station Additive Concentrate", "product_id": "65785-034_445cd72e-831c-98c4-e063-6294a90a7bdc", "dosage_form": "LIQUID", "pharm_class": ["Decreased Cell Wall Integrity [PE]"], "product_ndc": "65785-034", "generic_name": "Chlorhexidine gluconate and Propylene Glycol", "labeler_name": "Niagara Pharmaceuticals Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Eyewash Station Additive Concentrate", "active_ingredients": [{"name": "CHLORHEXIDINE GLUCONATE", "strength": "145.6 kg/2800L"}, {"name": "PROPYLENE GLYCOL", "strength": "280 kg/2800L"}], "application_number": "M018", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20111115", "listing_expiration_date": "20261231"}